Table 1.
Clinical characteristics of the HBsAg positive patients
| characteristics | HDV/HBV (n = 11) |
HBV (n = 214) |
P value |
|---|---|---|---|
| Age (yr) | 45.45 ± 14.94 | 41.39 ± 13.01 | .026 |
| Male:Female | 6/5 | 60/154 | .885 |
| ALT(IU/l) | 1485.65 ± 935.53 | 768.58 ± 824.03 | .006 |
| AST (IU/l) | 977.56 ± 939.71 | 424.29 ± 474.41 | .000 |
| HBV-DNA (log10 copies/mL) | 3.852.11 | 5.16 ± 2.00 | .038 |
| TBIL (μmol/L) | 80.71 ± 68.13 | 64.36 ± 87.19 | .942 |
| DBIL (μmol/L) | 73.07 ± 71.03 | 43.52 ± 63.15 | .446 |
| AKP(U/L) | 151.30 ± 66.58 | 114,01 ± 63.52 | .442 |
| γ-GT(U/L) | 196.34 ± 119.76 | 144.93 ± 122.32 | .064 |
IU international unit; data are given as median with range, ALT alanine aminotransferase, AST aspartate aminotransferase, TBIL total bilirubin, DBIL direct bilirubin, AKP alkaline phosphatase, γ-GT γ-glutamyl-transferase. P values are presented for comparisons between HBV-HDV positivity vs. HBV monopositivity